医薬化合物

Japanese Patent JP2002541236

A

Compounds or their salts having general formulas (I) and (II) wherein: s=is an integer equal to 1 or 2, preferably s=2; b0=0 or 1; A is the radical of a drug and is such as to meet the pharmacological tests reported in the description, C and C₁ are two bivalent radicals. The precursors of the radicals B and B₁ are such as to meet the pharmacological test reported in the description.

デル ソルダト，ピエロ

JP2000610818A

December 03, 2002

April 11, 2000

Click for automatic bibliography generation  

ニコックス エス エイ

C07D499/64; A61K31/21; A61K31/225; A61K31/366; A61K31/4172; A61K31/4178; A61K31/426; A61K31/431; A61K31/4439; A61K31/473; A61K31/663; A61K31/704; A61K38/00; A61P1/00; A61P1/04; A61P9/00; A61P9/02; A61P9/10; A61P9/12; A61P11/00; A61P11/06; A61P13/10; A61P15/08; A61P15/10; A61P17/00; A61P17/08; A61P19/04; A61P25/00; A61P25/28; A61P29/00; A61P31/00; A61P39/06; A61P43/00; C07C211/42; C07C211/49; C07C219/06; C07C219/22; C07C219/24; C07C271/28; C07D219/10; C07D233/64; C07D277/06; C07D277/14; C07D309/30; C07D401/12; C07D405/14; C07D417/06; C07D471/04; C07D473/18; C07D495/04; C07D499/68; C07F9/38; C07F9/40; C07H15/252; C07K5/02; (IPC1-7): C07C219/06; A61K31/366; A61K31/4178; A61K31/431; A61K31/4439; A61K31/704; A61K38/00; A61P1/00; A61P1/04; A61P9/00; A61P9/02; A61P9/10; A61P9/12; A61P11/00; A61P11/06; A61P13/10; A61P15/08; A61P15/10; A61P17/00; A61P17/08; A61P19/04; A61P25/00; A61P25/28; A61P29/00; A61P31/00; A61P39/06; A61P43/00; C07C219/22; C07C219/24; C07D219/10; C07D233/64; C07D277/06; C07D277/14; C07D309/30; C07D401/12; C07D405/14; C07D471/04; C07D495/04; C07D499/64; C07F9/40; C07H15/252

JPH07500355A	1995-01-12
JPH09512798A	1997-12-22

WO1993001163A1

1993-01-21

JPN5002005464, Ｇ　ＣＩＲＩＮＯ, ＢＲＩＴＩＳＨ　ＪＯＵＲＮＡＬ　ＯＦ　ＰＨＡＲＭＡＣＯＬＯＧＹ, 199604, Ｖ１１７Ｎ７, Ｐ１４２１−１４２６, GB, ＳＴＯＣＫＴＯＮ　ＰＲＥＳＳ
JPN5002005465, Ｇ　ＢＥＮＩＮＩ, ＪＯＵＲＮＡＬ　ＯＦ　ＰＨＡＲＭＡＣＥＵＴＩＣＡＬ　ＳＣＩＥＮＣＥＳ, 199501, Ｖ８４Ｎ１, Ｐ９３−９５, US, ＡＭＥＲＩＣＡＮ　ＰＨＡＲＭＡＣＥＵＴＩＣＡＬ　ＡＳＳＯＣＩＡＴＩＯＮ

野河 信太郎

Previous Patent: JP2002541235

Next Patent: カスパーゼインヒビターおよびその使用